Avandia News |
| |
We have compiled the latest news on Avandia. If you or a loved one has suffered heart problems while using Avandia and you would like more information about
your legal rights, please contact us. |
 |
|
GlaxoSmithKline Plc has agreed to pay about $460 million to resolve a majority of the lawsuits alleging its Avandia diabetes drug caused heart attacks and strokes, Bloomberg News reported on Tuesday.
Glaxo has agreed to settle about 10,000 cases at an average of at least $46,000 each, the report said, citing unnamed sources. |
|
| |
The drug maker GlaxoSmithKline misinterpreted crucial details of a study finding that Avandia, its blockbuster diabetes drug, is safe, a medical reviewer for the Food and Drug Administration said Friday.
Correctly interpreted, the study actually supports critics' contentions that Avandia may cause heart attacks, said the reviewer, Dr. Thomas Marciniak, in a posting on the F.D.A.'s Web site.
The company's misreadings of the study, known as the Record trial, were so profound, he concluded, that they "suggest serious flaws with trial conduct." |
| |
|
It's scary enough that a widely prescribed diabetes drug, Avandia, was shown in new studies this week to pose a substantially greater risk of heart attacks for users.
But what should really get consumers freaked is that healthcare experts and federal regulators say this isn't really surprising. When it comes to drug safety, they say, you can't make an omelet without breaking a few eggs. |
 |
|
A Senate report said Saturday that drug maker GlaxoSmithKline knew of possible heart attack risks tied to Avandia, its diabetes medication, years before such evidence became public.
Sen. Max Baucus, chairman of the Senate Finance Committee, and Chuck Grassley, the committee's ranking Republican, released the report, which follows a two-year inquiry, on Saturday. They are also asking the U.S. Food and Drug Administration why it allowed a clinical trial of Avandia to continue even after the agency estimated that the drug caused 83,000 heart attacks between 1999 and 2007. |
| |
|
Long-term use of the family of diabetes drugs that includes rosiglitazone and pioglitazone doubles the risk of bone fractures in women, but not in men, according to a new analysis of several large clinical trials.
Diabetic women are already at a higher than normal risk of fractures, experts said, so a doubling of risk could have a substantial effect. |
| |
|
An article in a leading medical journal yesterday raised serious safety questions about the widely used diabetes pill Avandia and renewed skepticism about the vigilance of federal drug regulators.
The analysis, based on a review of more than 40 existing clinical studies involving nearly 28,000 patients, showed that Avandia significantly increased the risk of heart attacks, compared with other diabetes drugs or a placebo. |
| |
|
| The biggest-selling diabetes drug in the world dramatically increases the risk of heart attacks and death from heart problems, according to an analysis by a top cardiologist published online in The New England Journal of Medicine. |
 |
|
U.S. regulators are reviewing the safety of GlaxoSmithKline's diabetes drug Avandia ut have not yet determined the significance of risks reported in a study released on Monday, a U.S. Food and Drug Administration official said.
A study published in The New England Journal of Medicine said Avandia increased the risk of cardiac-related deaths by 64 percent and heart attacks by 43 percent. Dr. Robert Meyer, head of the FDA office that reviews diabetes drugs, said other data contradicted those findings. |
|
 |
O'Steen & Harrison, PLC |
300 W. Clarendon Ave., Suite 400
Phoenix, Arizona 85013-3424
800.883.8888
info@vanosteen.com
|
Your Legal Rights |
If you or a loved one has experienced heart problems while using Avandia, you may be entitled to
compensation.
You
should act immediately to contact a lawyer experienced in matters involving dangerous pharmaceuticals.
|
 |
Contact Us |
|
|
